Sonark Pharmaceutical Private Limited
About Sonark Pharmaceutical Private Limited
Data last updated:
Sonark Pharmaceutical Private Limited is a private limited company based in Satara, Maharashtra, India. It operates in the ayurvedic products and services segment of the healthcare sector. It was incorporated on 19 October 1988 and has been in existence for over 38 years.
The company is registered with the Registrar of Companies (ROC), Pune, under CIN U24232MH1988PTC049307. Its GSTIN is 27AADCS7786B1Z4 (Maharashtra).
The company has an authorised share capital of ₹50 Lakh and a paid-up capital of ₹40 Lakh. It is led by directors including Girish Sudhakar Soman and Devendra Girish Soman.
Its last annual general meeting (AGM) was held on 29 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Aushadh Nirmanbhavan Plot No. J – 13/17 Additional MIDC, Satara, Maharashtra, India – 415004.
As per the financials filed for FY 2024, the company reported a revenue of ₹1.15 Cr, a growth of 25% compared to the previous year. For the same year it recorded a net profit of ₹7.33 Lakh (net margin 6.3%) and EBITDA of ₹15.05 Lakh (EBITDA margin 13%). Revenue has grown at a compounded annual rate (CAGR) of 4% over three years and 4% over five years.
The company has about 15 employees on its provident fund (EPFO) records.
As per MCA filings, the company has open charges of ₹75 Lakh on record.
The current compliance status is marked as compliant by the Registrar of Companies.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressAushadh Nirmanbhavan Plot No. J – 13/17 Additional MIDC, Satara, Maharashtra, India – 415004
- IndustryHealthcare, Ayurvedic Products & Services
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Sonark Pharmaceutical Private Limited
The main business activity of Sonark Pharmaceutical is manufacturing. In detail, this covers manufacture of basic pharmaceutical products and pharmaceutical preparations.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | 21 | Manufacture of basic pharmaceutical products and pharmaceutical preparations | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Sonark Pharmaceutical Private Limited FY 2025 filings available
Sonark Pharmaceutical Private Limited reported revenue of ₹1.15 Cr (up 25% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR) of Sonark Pharmaceutical Private Limited
Revenue has grown at a compounded annual rate (CAGR) of 4% over five years, including 25% growth in the latest year. EBITDA rose 23% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Sonark Pharmaceutical Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹15.05 Lakh | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹7.33 Lakh | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Sonark Pharmaceutical Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 13% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 6.3% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Sonark Pharmaceutical are in the company report.
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Board of Directors of Sonark Pharmaceutical Private Limited
Sonark Pharmaceutical has 4 current directors and 11 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Girish Sudhakar Soman Also directs: World Neem Organisation, Tru-Uth DMK India Private Limited, Nisarga Biotech Private Limited and 4 more | Director | 14 Dec 2009 | 16 Years 10 Months | Current |
| Devendra Girish Soman Also directs: Tru-Uth DMK India Private Limited, Nisarga Biotech Private Limited, Nuaxon Innovations Private Limited and 1 more | Director | 23 Feb 2022 | 4 Years 7 Months | Current |
| Tanmay Girish Soman | Director | 23 Feb 2022 | 4 Years 7 Months | Current |
| Arati Devendra Soman Also directs: Nisarga Biotech Private Limited | Director | 29 Sep 2023 | 3 Years 0 Months | Current |
Peer Comparison of Sonark Pharmaceutical Private Limited
Sonark Pharmaceutical Private Limited is compared with the companies closest to it by revenue in the Healthcare industry (Ayurvedic Products and Services). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Ocean Lifecare Private Limited | ₹1.17 Cr (FY 2024) | •••• | •••• | -10.0% | •••• | Pune, Maharashtra, India |
| Hope Ayurvedic Medicines Private Limited | ₹1.17 Cr (FY 2024) | •••• | •••• | 86.0% | •••• | Pune, Maharashtra, India |
| Chandrodaya Ayu Pharma Private Limited | ₹1.16 Cr (FY 2024) | •••• | •••• | -14.0% | •••• | Ahmedabad, Gujarat, India |
| Ashtapathy Health Care Private Limited | ₹1.16 Cr (FY 2022) | •••• | •••• | -75.0% | •••• | Aluva, Kerala, India |
| Saswat Healthcare Private Limited | ₹1.16 Cr (FY 2018) | •••• | •••• | 52.0% | •••• | Ahmedabad, Gujarat, India |
| Sonark Pharmaceutical Private Limited this company | ₹1.15 Cr (FY 2024) | •••• | •••• | 25.0% | •••• | Satara, Maharashtra, India |
| Vyasa Healthcare Private Limited | ₹1.15 Cr (FY 2025) | •••• | •••• | -1.0% | •••• | Bengaluru, Karnataka, India |
| Paras Ayurvedic Pharma Private Limited | ₹1.15 Cr (FY 2023) | •••• | •••• | 17.0% | •••• | Mumbai, Maharashtra, India |
| Dhanvarsha Industries & Biotechnology Private Limited | ₹1.15 Cr (FY 2025) | •••• | •••• | 57.0% | •••• | Lucknow, Uttar Pradesh, India |
| BS Ayurveda Tours India Private Limited | ₹1.14 Cr (FY 2022) | •••• | •••• | 658.0% | •••• | New Delhi, Delhi, India |
| Sunny Neem Extracts Private Limited | ₹1.14 Cr (FY 2019) | •••• | •••• | -4.0% | •••• | Panjagutta, Hyderabad, Telangana, India |
Peers are the five companies nearest above and the five nearest below Sonark Pharmaceutical by revenue in the Healthcare industry (Ayurvedic Products and Services), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Sonark Pharmaceutical Private Limited
Sonark Pharmaceutical Private Limited is audited by SWAPNIL K. BACHUTE & CO. for the financial year 2023.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| SWAPNIL K. BACHUTE & CO. | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Ownership and Shareholding of Sonark Pharmaceutical Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Sonark Pharmaceutical Private Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 14 Oct 2015 | Idbi Bank Limited | ₹17 Lakh | Open |
| 04 Sep 2010 | Idbi Bank Limited | ₹58 Lakh | Open |
Total charge records: 2 View all charges
MSME Payment Delays by Sonark Pharmaceutical Private Limited
Sonark Pharmaceutical Private Limited has 5 MSME Form 1 returns on record between 2019 and 2022, listing 49 overdue payments to 11 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (5 of 11)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| an individual supplier | •••• | •••• | •••• |
| Amsar Private Limited | •••• | •••• | •••• |
| Perfect Plasitc | •••• | •••• | •••• |
| an individual supplier | •••• | •••• | •••• |
| Santosh Ayurvedic Drug Supply Co. | •••• | •••• | •••• |
Full MSME payment history
Every supplier, amount and due date from all 5 MSME Form 1 returns is in the company report.
- Every reported supplier due
- Amounts and due dates
- Reasons given in each return
- Period-by-period history
Verified entity values are shown only after access is granted.
Individuals and sole proprietors among the suppliers are not named. Amounts, due dates and filing dates are in the company report.
Employees and EPFO Compliance at Sonark Pharmaceutical Private Limited
Sonark Pharmaceutical Private Limited has a workforce of 15 employees as of Nov 29, 2024.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Group Structure of Sonark Pharmaceutical Private Limited
Sonark Pharmaceutical has 5 associated companies. This group structure data is as of FY 2024. The table lists each entity with its relationship and holding.
Recent Activity on Sonark Pharmaceutical Private Limited
Sonark Pharmaceutical Private Limited has 26 board changes on record since 1988: 15 appointments and 11 cessations. The latest: Jalindar Shrirang Shinde ceased to be Director on 01 Jan 2026.
20 earlier events are listed in the company report.
Credit Ratings, Litigation & Regulatory Alerts for Sonark Pharmaceutical Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Sonark Pharmaceutical Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Sonark Pharmaceutical Private Limited
Sonark Pharmaceutical has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AADCS7786B1Z4 | Maharashtra | Active | 01 Jul 2017 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Sonark Pharmaceutical Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Sonark Pharmaceutical Private Limited
Sonark Pharmaceutical is an active private limited company based in Satara, Maharashtra, India. The company works in ayurvedic products and services, within the healthcare industry. It was incorporated on 19 October 1988 (38+ years old) and is registered under CIN U24232MH1988PTC049307.
Sonark Pharmaceutical reported revenue of ₹1.15 Cr for FY 2024 (up 25% YoY).
Sonark Pharmaceutical has 4 current directors:
- Girish Sudhakar Soman - Director
- Devendra Girish Soman - Director
- Tanmay Girish Soman - Director
- Arati Devendra Soman - Director
Sonark Pharmaceutical reported a net profit of ₹7.33 Lakh (net margin 6.3%) and EBITDA of ₹15.05 Lakh (EBITDA margin 13%) for FY 2024, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Sonark Pharmaceutical is 4% over three years and 4% over five years. In the latest year (FY 2024) revenue rose 25%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Sonark Pharmaceutical is 27AADCS7786B1Z4, registered in Maharashtra.
The CIN (Corporate Identification Number) of Sonark Pharmaceutical is U24232MH1988PTC049307. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Sonark Pharmaceutical was incorporated on 19 October 1988, making it 38+ years old. It is registered with the Registrar of Companies, Pune.
The peers of Sonark Pharmaceutical by revenue are Ocean Lifecare Private Limited, Hope Ayurvedic Medicines Private Limited, Chandrodaya Ayu Pharma Private Limited, Ashtapathy Health Care Private Limited, Saswat Healthcare Private Limited and 5 more, all in the Healthcare industry (Ayurvedic Products and Services).
Jalindar Shrirang Shinde ceased to be Director on 01 Jan 2026. Renuka Shantanu Shinde ceased to be Director on 01 Jan 2026. Shantanu Jalindar Shinde ceased to be Director on 01 Jan 2026. Sonark Pharmaceutical has 26 board changes on record in total.
Sonark Pharmaceutical has 5 MSME Form 1 returns on record between 2019 and 2022, listing 49 overdue payments to 11 micro and small suppliers. The latest return was filed on 30 Apr 2022.
The registered office of Sonark Pharmaceutical is at Aushadh Nirmanbhavan Plot No. J – 1317 Additional MIDC, Satara, Maharashtra, India – 415004.